CN102391186A - Method for preparing ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate - Google Patents

Method for preparing ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate Download PDF

Info

Publication number
CN102391186A
CN102391186A CN201110293149XA CN201110293149A CN102391186A CN 102391186 A CN102391186 A CN 102391186A CN 201110293149X A CN201110293149X A CN 201110293149XA CN 201110293149 A CN201110293149 A CN 201110293149A CN 102391186 A CN102391186 A CN 102391186A
Authority
CN
China
Prior art keywords
methyl
acetone
kilograms
preparation
imidazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201110293149XA
Other languages
Chinese (zh)
Other versions
CN102391186B (en
Inventor
杨彦军
于东海
胡俊峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd.
Original Assignee
JINAN CHENGHUI SHUANGDA CHEMICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JINAN CHENGHUI SHUANGDA CHEMICAL CO Ltd filed Critical JINAN CHENGHUI SHUANGDA CHEMICAL CO Ltd
Priority to CN201110293149XA priority Critical patent/CN102391186B/en
Publication of CN102391186A publication Critical patent/CN102391186A/en
Application granted granted Critical
Publication of CN102391186B publication Critical patent/CN102391186B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a method for preparing an ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate, which comprises the following steps of: (1) sodium imidazolide preparation: (1.1) dissolving sodium hydroxides in deionized water, and after the sodium hydroxides is completely dissolved, stirring the obtained product and adding imidazolide to the obtained product; (1.2) putting the solution obtained in the step (1.1) into a reaction kettle and uniformly mixing to obtain a stand-by material; and (1.3) adding toluene to the stand-by material obtained in the step (1.2), then adding acetone to the obtained mixture to obtain an acetone solution; and (2) (E)-4-(imidazolyl-methyl) methyl cinnamate preparation: (2.1) adding methyl 3-(4-bromomethyl) cinnamate to the acetone solution, and after reaction, carrying out depressurized evaporation on the obtained product to remove acetone from the material; and (2.2) adding deionized water to the material subjected to acetone evaporation in the step (2.1), and stirring the obtained mixture to crystallize, thereby obtaining the (E)-4-(imidazolyl-methyl) methyl cinnamate. By using the method disclosed by the invention, the shortages existing in the prior art can be overcome, and the production cost of the intermediate is greatly reduced.

Description

The preparation method of a kind of ozagrel midbody (E)-4-(imidazolyl methyl) methyl cinnamate
Technical field
The present invention relates to medicine, is the preparation method of (E)-4-(imidazolyl methyl) methyl cinnamate in the middle of a kind of ozagrel.
Background technology
Ozagrel is a kind of antithrombotic, is a kind of powerful thrombus synthetase inhibitors.Because this medicine has prophylactic effect preferably to the cerebral infarction that the obstruction arteria cerebri media causes; Therefore; Be mainly used in the dyspraxia that treatment acute thrombotic cerebral infarction and cerebral infarction are followed, simultaneously, OKY-046 also can be used for bronchial asthma and anginal treatment etc.Because this medicine has broad application prospects, in order to reduce patient's use cost, the pharmacy corporation that China has is also making great efforts to produce this medicine, so that reach quality product height, purpose that production cost is low.Yet the midbody of this medicine (E)-4-(imidazolyl methyl) methyl cinnamate quality good or not in the preparation process directly influences the curative effect of ozagrel medicine, and all there is deficiency in this intermediates preparation of report: for example: adopt imidazoles and the brooethyl methyl cinnamate is reacted the methyl cinnamate through N-alkylation production (E)-4-(imidazolyl methyl); Impurity in this method reaction is generally all at 10-15%; Remove the process relative complex of impurity, be difficult to reach high purity, simultaneously; The productive rate of this method is generally about 75%; Productive rate is lower, and, the difficult control of temperature of reaction; The another kind of employing generates imidazoles bromine father-in-law salt with the reaction of N-acetyl imidazole to the brooethyl methyl cinnamate under nitrogen protection; Imidazoles bromine father-in-law salt obtains (E)-4-(imidazolyl methyl) methyl cinnamate through the yellow soda ash hydrolysis again; This method complicated operation; Reaction times is longer, and yield is lower, and still difficulty reduces production costs.
Summary of the invention
The purpose of this invention is to provide the preparation method of a kind of ozagrel midbody (E)-4-(imidazolyl methyl) methyl cinnamate, make it can solve the deficiency of prior art, this midbody production cost is significantly reduced.
The present invention is for realizing above-mentioned purpose, and realize through following technical scheme: the preparation method of a kind of ozagrel midbody (E)-4-(imidazolyl methyl) methyl cinnamate comprises the steps:
(1) preparation imidazole natrium:
(1.1) sodium hydroxide is dissolved in the deionized water, the dissolving back adds imidazoles under agitation condition, and the weight ratio of sodium hydroxide, deionized water and imidazoles is 1:1:1.62;
(1.2) with the solution in the step (1.1) insert mix in the reaction kettle after, 50-80 ℃ of down reaction 3-5 hour, vacuum decompression steams and removes the wherein moisture of 80%-90%, reduces to room temperature then and obtains subsequent use material;
(1.3) with adding toluene in the subsequent use material in the step (1.2), the weight ratio of toluene and imidazoles is 2.6:1, and reflux water-dividing removes toluene again under reduced pressure then, adds acetone after reducing to room temperature, obtains acetone soln, and the weight ratio of acetone and imidazoles is 4.9:1;
(2) preparation (E)-4-(imidazolyl methyl) methyl cinnamate:
(2.1) getting the brooethyl methyl cinnamate is dropped in the acetone soln, is 3.73:1 to the weight ratio of brooethyl methyl cinnamate and imidazoles, at room temperature reacts 3-4 hour, reacts to remove acetone under reduced pressure after finishing;
(2.2) in step (2.1), steam except that adding the deionized water and stirring crystallization in the material behind the acetone; Deionized water be 1.97:1 to the weight ratio of brooethyl methyl cinnamate; Carry out centrifugal getting rid of after the filter and and dried by the fire material 19-21 hour down, obtain (E)-4-(imidazolyl methyl) methyl cinnamate at 40-50 ℃.
Sodium hydroxide described in the step (1.1) adopts sodium hydrogencarbonate to substitute.
The preparation method of (E)-4-(imidazolyl methyl) methyl cinnamate comprises the steps: in the middle of described a kind of ozagrel
(1) preparation of imidazole natrium:
(1.1) 126 kilograms of sodium hydroxide are dissolved in 126 kilograms the deionized water, the dissolving back is 204 kilograms of imidazoles of adding under agitation condition, obtain mixing solutions;
(1.2) with the mixing solutions in the step (1.1) insert mix in the reaction kettle after, 74 ℃ of down reactions 3.8 hours, vacuum decompression steams and removes wherein 90% moisture, reduces to room temperature then and obtains subsequent use material;
(1.3) with adding 500 kilograms of toluene in the subsequent use material in the step (1.2), reflux water-dividing removes toluene again under reduced pressure then, adds 1000 kilograms of acetone after reducing to room temperature, obtains acetone soln;
(2) preparation (E)-4-(imidazolyl methyl) methyl cinnamate:
(2.1) get in 152.4 kilograms of inputs of brooethyl methyl cinnamate acetone soln, at room temperature reacted 3.5 hours, remove acetone under reduced pressure after reaction finishes;
(2.2) add 1500 kilograms deionized water and stirring crystallization in the material after step (2.1) steam to be removed acetone, carry out centrifugally getting rid of the filter back and, obtaining 135 kilograms of (E)-4-(imidazolyl methyl) methyl cinnamates at 46 ℃ of baking material 20 hours down.
(E)-4-(imidazolyl methyl) methyl cinnamate that adopts ozagrel intermediates preparation of the present invention to obtain has the high characteristics of purity, and purity can reach 99.8%, and yield is up to about 93%; And this method is easy and simple to handle; Reaction times is short, and the solvent that uses in the reaction is single, and reaction is control easily; Production cost is significantly reduced, thereby reduced production cost for the preparation of ozagrel.
Embodiment
The preparation method of a kind of ozagrel midbody of the present invention (E)-4-(imidazolyl methyl) methyl cinnamate comprises the steps:
(1) preparation imidazole natrium:
(1.1) sodium hydroxide is dissolved in the deionized water, the dissolving back adds imidazoles under agitation condition, and the weight ratio of sodium hydroxide, deionized water and imidazoles is 1:1:1.62;
(1.2) with the solution in the step (1.1) insert mix in the reaction kettle after, 50-80 ℃ of down reaction 3-5 hour, vacuum decompression steams and removes the wherein moisture of 80%-90%, reduces to room temperature then and obtains subsequent use material;
(1.3) with adding toluene in the subsequent use material in the step (1.2), the weight ratio of toluene and imidazoles is 2.6:1, and reflux water-dividing removes toluene again under reduced pressure then, adds acetone after reducing to room temperature, obtains acetone soln, and the weight ratio of acetone and imidazoles is 4.9:1;
(2) preparation (E)-4-(imidazolyl methyl) methyl cinnamate:
(2.1) getting the brooethyl methyl cinnamate is dropped in the acetone soln, is 3.73:1 to the weight ratio of brooethyl methyl cinnamate and imidazoles, at room temperature reacts 3-4 hour, reacts to remove acetone under reduced pressure after finishing;
(2.2) in step (2.1), steam except that adding the deionized water and stirring crystallization in the material behind the acetone; Deionized water be 1.97:1 to the weight ratio of brooethyl methyl cinnamate; Carry out centrifugal getting rid of after the filter and and dried by the fire material 19-21 hour down, obtain (E)-4-(imidazolyl methyl) methyl cinnamate at 40-50 ℃.
Sodium hydroxide described in the step (1.1) also can adopt sodium hydrogencarbonate to substitute.
The preparation method of (E)-4-(imidazolyl methyl) methyl cinnamate in the middle of a kind of ozagrel of the present invention, concrete steps are following:
(1) preparation of imidazole natrium:
(1.1) 126 kilograms of sodium hydroxide are dissolved in 126 kilograms the deionized water, the dissolving back is 204 kilograms of imidazoles of adding under agitation condition, obtain mixing solutions;
(1.2) with the mixing solutions in the step (1.1) insert mix in the 3000L reaction kettle after, 72 ℃ of down reactions 3.8 hours, vacuum decompression steams and removes wherein 90% moisture, reduces to room temperature then and obtains subsequent use material;
(1.3) with adding 500 kilograms of toluene in the subsequent use material in the step (1.2), reflux water-dividing removes toluene again under reduced pressure then, adds 1000 kilograms of acetone after reducing to room temperature, obtains acetone soln;
(2) preparation (E)-4-(imidazolyl methyl) methyl cinnamate:
(2.1) get in 152.4 kilograms of inputs of brooethyl methyl cinnamate acetone soln, at room temperature reacted 3.5 hours, remove acetone under reduced pressure after reaction finishes;
(2.2) add 1500 kilograms deionized water and stirring crystallization in the material after step (2.1) steam to be removed acetone, carry out centrifugally getting rid of the filter back and, obtaining 135 kilograms of (E)-4-(imidazolyl methyl) methyl cinnamates at 46 ℃ of baking material 20 hours down.Yield is 93.7%, and purity is 99.8%.
The preparation method of a kind of ozagrel midbody of the present invention (E)-4-(imidazolyl methyl) methyl cinnamate can adopt following method preparation:
Example 1:
(1) preparation imidazole natrium:
(1.1) 25.2 kilograms of sodium hydroxide are dissolved in 25.2 kilograms the deionized water, the dissolving back is 40.8 kilograms of imidazoles of adding under agitation condition, obtain mixing solutions;
(1.2) with the mixing solutions in the step (1.1) insert mix in the 500L reaction kettle after, 80 ℃ of down reactions 3 hours, vacuum decompression steams and removes wherein 90% moisture, reduces to room temperature then and obtains subsequent use material;
(1.3) with adding 100 kilograms of toluene in the subsequent use material in the step (1.2), reflux water-dividing removes toluene again under reduced pressure then, adds 200 kilograms of acetone after reducing to room temperature, obtains acetone soln;
(2) preparation (E)-4-(imidazolyl methyl) methyl cinnamate:
(2.1) get in 152.4 kilograms of inputs of brooethyl methyl cinnamate acetone soln, at room temperature reacted 3 hours, remove acetone under reduced pressure after reaction finishes;
(2.2) steam the deionized water and stirring crystallization that adds 300 kilograms in the material after removing acetone in step (2.1); Carry out centrifugal getting rid of after the filter and and dried by the fire material 21 hours down at 40 ℃; Obtain 135 kilograms of (E)-4-(imidazolyl methyl) methyl cinnamates, yield is 93.2%, and purity is 99.8%.
Example 2:
(1) preparation of imidazole natrium:
(1.1) 126 kilograms of sodium hydroxide are dissolved in 126 kilograms the deionized water, the dissolving back is 204 kilograms of imidazoles of adding under agitation condition, obtain mixing solutions;
(1.2) with the mixing solutions in the step (1.1) insert mix in the 3000L reaction kettle after, 70 ℃ of down reactions 5 hours, vacuum decompression steams and removes wherein 90% moisture, reduces to room temperature then and obtains subsequent use material;
(1.3) with adding 500 kilograms of toluene in the subsequent use material in the step (1.2), reflux water-dividing removes toluene again under reduced pressure then, adds 1000 kilograms of acetone after reducing to room temperature, obtains acetone soln;
(2) preparation (E)-4-(imidazolyl methyl) methyl cinnamate:
(2.1) get in 762 kilograms of inputs of brooethyl methyl cinnamate acetone soln, at room temperature reacted 4 hours, remove acetone under reduced pressure after reaction finishes;
(2.2) steam the deionized water and stirring crystallization that adds 1500 kilograms in the material after removing acetone in step (2.1); Carry out centrifugal getting rid of after the filter and and dried by the fire material 21 hours down at 50 ℃; Obtain 680.2 kilograms of (E)-4-(imidazolyl methyl) methyl cinnamates, yield is 93.7%, and purity is 99.8%.
Preparing method of the present invention, its reaction formula is following:
1, the preparation of imidazole natrium:
Figure 512158DEST_PATH_IMAGE002
2, the preparation of (E)-4-(imidazolyl methyl) methyl cinnamate:
Figure 264213DEST_PATH_IMAGE004

Claims (3)

1. the preparation method of an ozagrel midbody (E)-4-(imidazolyl methyl) methyl cinnamate is characterized in that: comprise the steps:
(1) preparation imidazole natrium:
(1.1) sodium hydroxide is dissolved in the deionized water, the dissolving back adds imidazoles under agitation condition, and the weight ratio of sodium hydroxide, deionized water and imidazoles is 1:1:1.62;
(1.2) with the solution in the step (1.1) insert mix in the reaction kettle after, 50-80 ℃ of down reaction 3-5 hour, vacuum decompression steams and removes the wherein moisture of 80%-90%, reduces to room temperature then and obtains subsequent use material;
(1.3) with adding toluene in the subsequent use material in the step (1.2), the weight ratio of toluene and imidazoles is 2.6:1, and reflux water-dividing removes toluene again under reduced pressure then, adds acetone after reducing to room temperature, obtains acetone soln, and the weight ratio of acetone and imidazoles is 4.9:1;
(2) preparation (E)-4-(imidazolyl methyl) methyl cinnamate:
(2.1) getting the brooethyl methyl cinnamate is dropped in the acetone soln, is 3.73:1 to the weight ratio of brooethyl methyl cinnamate and imidazoles, at room temperature reacts 3-4 hour, reacts to remove acetone under reduced pressure after finishing;
(2.2) in step (2.1), steam except that adding the deionized water and stirring crystallization in the material behind the acetone; Deionized water be 1.97:1 to the weight ratio of brooethyl methyl cinnamate; Carry out centrifugal getting rid of after the filter and and dried by the fire material 19-21 hour down, obtain (E)-4-(imidazolyl methyl) methyl cinnamate at 40-50 ℃.
2. the preparation method of (E)-4-(imidazolyl methyl) methyl cinnamate in the middle of a kind of ozagrel according to claim 1 is characterized in that: the sodium hydroxide described in the step (1.1) adopts sodium hydrogencarbonate to substitute.
3. the preparation method of (E)-4-(imidazolyl methyl) methyl cinnamate is characterized in that: comprise the steps: in the middle of a kind of ozagrel according to claim 1
(1) preparation of imidazole natrium:
(1.1) 126 kilograms of sodium hydroxide are dissolved in 126 kilograms the deionized water, the dissolving back is 204 kilograms of imidazoles of adding under agitation condition, obtain mixing solutions;
(1.2) with the mixing solutions in the step (1.1) insert mix in the reaction kettle after, 74 ℃ of down reactions 3.8 hours, vacuum decompression steams and removes wherein 90% moisture, reduces to room temperature then and obtains subsequent use material;
(1.3) with adding 500 kilograms of toluene in the subsequent use material in the step (1.2), reflux water-dividing removes toluene again under reduced pressure then, adds 1000 kilograms of acetone after reducing to room temperature, obtains acetone soln;
(2) preparation (E)-4-(imidazolyl methyl) methyl cinnamate:
(2.1) get in 152.4 kilograms of inputs of brooethyl methyl cinnamate acetone soln, at room temperature reacted 3.5 hours, remove acetone under reduced pressure after reaction finishes;
(2.2) add 1500 kilograms deionized water and stirring crystallization in the material after step (2.1) steam to be removed acetone, carry out centrifugally getting rid of the filter back and, obtaining 135 kilograms of (E)-4-(imidazolyl methyl) methyl cinnamates at 46 ℃ of baking material 20 hours down.
CN201110293149XA 2011-09-30 2011-09-30 Method for preparing ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate Active CN102391186B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110293149XA CN102391186B (en) 2011-09-30 2011-09-30 Method for preparing ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110293149XA CN102391186B (en) 2011-09-30 2011-09-30 Method for preparing ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate

Publications (2)

Publication Number Publication Date
CN102391186A true CN102391186A (en) 2012-03-28
CN102391186B CN102391186B (en) 2013-12-04

Family

ID=45858595

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110293149XA Active CN102391186B (en) 2011-09-30 2011-09-30 Method for preparing ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate

Country Status (1)

Country Link
CN (1) CN102391186B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103613546A (en) * 2013-12-11 2014-03-05 青岛农业大学 Chemical synthesizing method of ozagrel
CN103787980A (en) * 2014-01-21 2014-05-14 济南信和缘科技有限公司 Preparation method for ozagrel intermediate
CN104761500A (en) * 2014-01-08 2015-07-08 济南大成医药发展有限公司 Preparation method of (E)-4-(1-imidazole methyl)methyl cinnamate
CN105481771A (en) * 2015-12-29 2016-04-13 济南诚汇双达化工有限公司 Preparation process of ozagrel intermediate methyl (E)-4-(imidazolylmethyl) cinnamate
CN108084094A (en) * 2017-11-09 2018-05-29 江苏康乐佳材料有限公司 A kind of technique that imidazole natrium is prepared as raw material using imidazoles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3105367B2 (en) * 1992-10-15 2000-10-30 日本合成化学工業株式会社 Method for producing 4- (1-imidazolylmethyl) cinnamic acid
CN101704786A (en) * 2009-10-28 2010-05-12 陶灵刚 High-purity ozagrel compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3105367B2 (en) * 1992-10-15 2000-10-30 日本合成化学工業株式会社 Method for producing 4- (1-imidazolylmethyl) cinnamic acid
CN101704786A (en) * 2009-10-28 2010-05-12 陶灵刚 High-purity ozagrel compound

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
《南昌大学学报(理科版)》 19980930 徐双美 等 血栓素合成酶抑制剂--奥札格雷的合成研究 288-290 1-3 第22卷, 第3期 *
KINJI IIZUKA ET AL.: "Highly Selective Inhibitors of Thromboxane Synthetase. 1. Imidazole Derivatives", 《J. MED. CHEM.》, vol. 24, no. 10, 31 December 1981 (1981-12-31), pages 1139 - 1148 *
徐双美 等: "血栓素合成酶抑制剂——奥札格雷的合成研究", 《南昌大学学报(理科版)》, vol. 22, no. 3, 30 September 1998 (1998-09-30), pages 288 - 290 *
薛叙明 等: "奥扎格雷合成工艺", 《化工进展》, vol. 28, no. 11, 31 December 2009 (2009-12-31), pages 2024 - 2027 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103613546A (en) * 2013-12-11 2014-03-05 青岛农业大学 Chemical synthesizing method of ozagrel
CN104761500A (en) * 2014-01-08 2015-07-08 济南大成医药发展有限公司 Preparation method of (E)-4-(1-imidazole methyl)methyl cinnamate
CN104761500B (en) * 2014-01-08 2017-11-21 济南大成医药发展有限公司 (E) preparation method of 4 (1 imidazolmethyl) methyl cinnamates
CN103787980A (en) * 2014-01-21 2014-05-14 济南信和缘科技有限公司 Preparation method for ozagrel intermediate
CN105481771A (en) * 2015-12-29 2016-04-13 济南诚汇双达化工有限公司 Preparation process of ozagrel intermediate methyl (E)-4-(imidazolylmethyl) cinnamate
CN108084094A (en) * 2017-11-09 2018-05-29 江苏康乐佳材料有限公司 A kind of technique that imidazole natrium is prepared as raw material using imidazoles

Also Published As

Publication number Publication date
CN102391186B (en) 2013-12-04

Similar Documents

Publication Publication Date Title
CN102391186A (en) Method for preparing ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate
CN104910178A (en) Method for preparing piperacillin acid
CN101602716B (en) Synthesis method of 2-chromium picolinate
CN101260127B (en) Method for synthesizing trichlorosucrose by deacetylation of trichlorosucrose-6-ethyl ester
CN101781264B (en) Production method of 1-methyl-5-mercapto-1,2,3,4-tetrazole
CN101875671A (en) Synthesis method of glyphosate
CN105646580A (en) Method for producing pentahydrate s-ornidazole disodium phosphate
WO2016202252A1 (en) Method for synthesizing d-para-hydroxyphenylglycine methyl ester
CN101108824B (en) Method for synthesizing 2- chlorine -3- cyanogen radical pyridine with 3- cyanogen radical pyridine
CN104496937A (en) Synthetic method of 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate
CN104326975A (en) Preparation method of high-purity milrinone
CN103087201B (en) Production technology for preparing hyperviscous industrial-grade cellulose glycolate by means of half aqueous medium process
CN103588765A (en) Synthesis method for azilsartan medoxomil or salt thereof, intermediate of azilsartan medoxomil or salt thereof and synthesis method for intermediate
CN109456347A (en) A kind of preparation method of gram of vertical boron sieve
US20090018339A1 (en) Process For Preparing Crystalline Form A Of Lansoprazole
CN109293590A (en) A method of promoting triazine ring product quality
CN103159675A (en) Method for preparing 2, 3-pyridine acid
CN103030599B (en) Gefitinib intermediate and preparation method thereof
CN101928278A (en) (S)-4-[(4-chlorphenyl)(pyridine-2-yl)methoxyl]piperidinehydroxyphenpropionate and application thereof
CN105481771B (en) A kind of preparation process of ozagrel intermediate (E) -4- (imidazolyl methyl) methyl cinnamate
CN105837635B (en) A kind of preparation method for being used to treat the minodronic acid of osteoporosis
CN103664758B (en) The synthetic method of Mexidole
CN106866560A (en) A kind of synthetic method of Lesinurad
CN110551027B (en) Synthetic method of 3-hydroxy-2-phenylpropionic acid
WO2015151190A1 (en) Method for producing irsogladine maleate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190211

Address after: 253100 Shandong Province Plain of Dezhou City Economic Development Zone north two Ring Road West first northbound Shandong Yunjia Pharmaceutical Co. Ltd.

Patentee after: Shandong Yunjia Pharmaceutical Co. Ltd.

Address before: 250101 2350 development road, hi tech Development Zone, Ji'nan, Shandong

Patentee before: Jinan Chenghui Shuangda Chemical Co., Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200518

Address after: 250101 First, Second and Fourth Floors of Quality Inspection Building No. 2350 Kaixin Road, Jinan High-tech Zone, Shandong Province

Patentee after: Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd.

Address before: 253100 Shandong Dezhou Plain Economic Development Zone North Second Ring Road West First Road North Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.

Patentee before: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL Co.,Ltd.